Shanghai Top Medicine & Technology Co. Ltd, Shanghai, China.
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2539-2547. doi: 10.26355/eurrev_202003_20521.
Lung cancer has an unfavorable prognosis due to the lack of efficient diagnostic and therapeutic strategies. Therefore, this study sought to figure out the effect of long non-coding RNA (lncRNA) DANCR on lung cancer progression.
LncRNA DANCR and miR-214-5p expressions in non-small cell lung cancer (NSCLC) were detected by Real Time-quantitative Polymerase Chain Reaction (RT-qPCR). Function assays, including Cell Counting Kit-8 (CCK-8) and flow cytometric analysis were conducted to clarify the role of DANCR and miR-214-5p in the progression of NSCLC. Western blot, Dual-Luciferase reporter assay, and RNA immunoprecipitation assay (RIP) were performed to elucidate the underlying mechanism.
LncRNA DANCR was upregulated in NSCLC. The knockdown of lncRNA DANCR inhibited cell proliferation and accelerated cell apoptosis in NSCLC. LncRNA DANCR interacted with miR-214-5p. MiR-214-5p over-expression partially reversed the regulatory effects of DANCR on proliferation and apoptosis in NSCLC. In addition, CIZ1 was the downstream gene binding miR-214-5p. LncRNA DANCR could regulate the miR-214-5p/CIZ1 axis.
Downregulation of lncRNA DANCR inhibited cell proliferation and induced cell apoptosis in NSCLC by regulating the miR-214-5p/CIZ1 axis. LncRNA DANCR may act as an oncogene and promote the progression of NSCLC.
由于缺乏有效的诊断和治疗策略,肺癌的预后不佳。因此,本研究旨在探讨长链非编码 RNA(lncRNA)DANCR 对肺癌进展的影响。
采用实时定量聚合酶链反应(RT-qPCR)检测非小细胞肺癌(NSCLC)中 lncRNA DANCR 和 miR-214-5p 的表达。通过细胞计数试剂盒-8(CCK-8)和流式细胞术分析进行功能测定,以阐明 DANCR 和 miR-214-5p 在 NSCLC 进展中的作用。采用 Western blot、双荧光素酶报告基因检测和 RNA 免疫沉淀(RIP)实验来阐明潜在的机制。
lncRNA DANCR 在 NSCLC 中上调。lncRNA DANCR 的敲低抑制了 NSCLC 中的细胞增殖并加速了细胞凋亡。lncRNA DANCR 与 miR-214-5p 相互作用。miR-214-5p 的过表达部分逆转了 DANCR 对 NSCLC 增殖和凋亡的调节作用。此外,CIZ1 是与 miR-214-5p 结合的下游基因。lncRNA DANCR 可以调节 miR-214-5p/CIZ1 轴。
下调 lncRNA DANCR 通过调节 miR-214-5p/CIZ1 轴抑制 NSCLC 中的细胞增殖并诱导细胞凋亡。lncRNA DANCR 可能作为癌基因促进 NSCLC 的进展。